Public Company News
Nezha Craze Sweeps the City Wai Yuen Tong Proudly Sponsors Broadcast of "Nezha: The Demon Child Comes into the World" on Jade Channel
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Hong Kong's traditional Chinese medicine pioneer Wai Yuen Tong (0897.HK) announced its proud sponsorship of the TVB Jade Channel's broadcast of the film " Nezha: The Demon Child Comes into the World " (Nezha 1) onFebruary 28 at 8 PM. This film will provid...
Canadian Solar Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call for March 25
KITCHENER, ON, Feb. 27, 2025 /PRNewswire/ -- Canadian Solar Inc
ASUS "Design You Can Feel" at Milan Design Week 2025
MILAN, Feb. 27, 2025 /PRNewswire/ -- Following last year's success at London
Design Festival, ASUS bringsDesign You Can Feel
So-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period
BEIJING, Feb. 27, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that onFebruary 25, 2025, the...
Daqo New Energy Announces Unaudited Fourth Quarter and Fiscal Year 2024 Results
SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results for the fourth quarter and fiscal year of 2024. ...
Minesto publishes Year-End Report 2024
GOTHENBURG, Sweden, Feb. 27, 2025 /PRNewswire/ -- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and proprietary innovation." Significant events October - December 2024 Minesto's work towards t...
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies inAustralia. AK138D1, a self-developed and differentiated HER3-targeting ADC (antibody-drug conjugate)...
Kuaishou Technology to Report 2024 Fourth Quarter and Full Year Financial Results on March 25, 2025
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that it will report its financial results for the fourth quarter and full fis...
Sinch Makes RCS Accessible for All Businesses with Simple and Fast Set-Up and Launch
STOCKHOLM, Feb. 27, 2025 /PRNewswire/ -- Sinch (Sinch AB (publ)) – (XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is set to demonstrate its latest innovations with Rich Communication Services (RCS) for Business at Mobile World Congress...
Ericsson Annual Report 2024 published
* The Annual Report 2024 available for download and printed version available for order * The Annual Report 2024 publication consists of Ericsson's Financial report 2024, the Corporate Governance report 2024, the Remuneration report 2024 and the Sustainability and Corporate Responsibility rep...
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection byJapan's Pharmaceuticals and Medical Devices Agency (PMDA) for it...
SKF: Notice of Annual General Meeting
GOTHENBURG, Sweden, Feb. 27, 2025 /PRNewswire/ -- Notice is hereby given that the Annual General Meeting of Aktiebolaget SKF will be held at Radisson Blu Scandinavia Hotel, Södra Hamngatan 59,Gothenburg, Sweden, at 14.00 on Tuesday, 1 April 2025. The doors are open from 13.00. Light refreshments ...
Kia and Samsung Partner to Integrate SmartThings Pro into Kia PBVs
- Kia and Samsung collaborate to enhance the digital ecosystem of Kia's Platform Beyond Vehicles (PBVs) for business - Samsung's B2B IoT platform – 'SmartThings Pro' – will be integrated into Kia PBVs for seamless connectivity between vehicles and business environments - ...
Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America
New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing?, sheddi...
Revolutionizing All-on-X: Medit's Game-Changing Workflow Will Launch Soon
SEOUL, South Korea and NEWPORT BEACH, Calif., Feb. 27, 2025 /PRNewswire/ --
Medit (www.medit.com
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 27, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-301) of anti-HER2 bip...
YUEWEN WONDERLAND Daily Footfall Surpasses 20K+ Visitors as 'Goods Economy' Ignites Singapore
SINGAPORE, Feb. 27, 2025 /PRNewswire/ -- The one-month-long YUEWEN WONDERLAND event at Marina Bay Sands culminated successfully, marking a significant milestone in cross-cultural IP activation. Leveraging Yuewen's vast IP portfolio, the event focused on the emerging "Goods Economy" trend—defined ...
The debate on MSCs is over; it's time to promote MSC therapy in practice
TIANJIN, China, Feb. 27, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The major issue focuses on mesenchymal stem cells could no...
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection byJapan's Pharmaceuticals and Medical Devices Agency (PMDA) for it...
Future of airport operations to take centre stage at inter airport Southeast Asia conference
A spotlight on industry experts that will lead key conversations on making airports inAsia more sustainable. SINGAPORE, Feb. 27, 2025 /PRNewswire/ -- Themed "Airport Operations for Tomorrow", inter airportSoutheast Asia 2025 (IASEA) curated a lineup of conference sessions and the latest innovati...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00